Relevant Features in Nonalcoholic Steatohepatitis Determined Using Machine Learning for Feature Selection

Metab Syndr Relat Disord. 2019 Nov;17(9):444-451. doi: 10.1089/met.2019.0052.

Abstract

Aim: We investigated the prevalence and the most relevant features of nonalcoholic steatohepatitis (NASH), a stage of nonalcoholic fatty liver disease, (NAFLD) in which the inflammation of hepatocytes can lead to increased cardiovascular risk, liver fibrosis, cirrhosis, and the need for liver transplant. Methods: We analyzed data from 2239 hypertensive patients using descriptive statistics and supervised machine learning algorithms, including the least absolute shrinkage and selection operator and random forest classifier, to select the most relevant features of NASH. Results: The prevalence of NASH among our hypertensive patients was 11.3%. In univariate analyses, it was associated with metabolic syndrome, type 2 diabetes, insulin resistance, and dyslipidemia. Ferritin and serum insulin were the most relevant features in the final model, with a sensitivity of 70%, specificity of 79%, and area under the curve of 0.79. Conclusion: Ferritin and insulin are significant predictors of NASH. Clinicians may use these to better assess cardiovascular risk and provide better management to hypertensive patients with NASH. Machine-learning algorithms may help health care providers make decisions.

Keywords: machine learning; metabolic syndrome; nonalcoholic steatohepatitis.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adult
  • Aged
  • Algorithms*
  • Cross-Sectional Studies
  • Decision Making*
  • Diabetes Mellitus, Type 2 / complications
  • Diabetes Mellitus, Type 2 / epidemiology
  • Disease Progression
  • Female
  • Humans
  • Hypertension / complications
  • Hypertension / epidemiology
  • Liver Cirrhosis / complications
  • Liver Cirrhosis / epidemiology
  • Machine Learning*
  • Male
  • Metabolic Syndrome / complications
  • Metabolic Syndrome / epidemiology
  • Middle Aged
  • Non-alcoholic Fatty Liver Disease / diagnosis*
  • Non-alcoholic Fatty Liver Disease / epidemiology
  • Non-alcoholic Fatty Liver Disease / pathology
  • Non-alcoholic Fatty Liver Disease / therapy*
  • Prevalence
  • Prognosis
  • Retrospective Studies
  • Sensitivity and Specificity
  • Severity of Illness Index